- Home
- AUDC vs DRTS Comparison
AUDC vs DRTS Comparison
Compare AUDC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- DRTS
- Stock Information
- Founded
- AUDC 1992
- DRTS 2015
- Country
- AUDC Israel
- DRTS Israel
- Employees
- AUDC N/A
- DRTS N/A
- Industry
- AUDC Telecommunications Equipment
- DRTS Medical/Dental Instruments
- Sector
- AUDC Utilities
- DRTS Health Care
- Exchange
- AUDC Nasdaq
- DRTS Nasdaq
- Market Cap
- AUDC 282.4M
- DRTS 274.0M
- IPO Year
- AUDC 1999
- DRTS N/A
- Fundamental
- Price
- AUDC $10.16
- DRTS $3.01
- Analyst Decision
- AUDC Buy
- DRTS Strong Buy
- Analyst Count
- AUDC 3
- DRTS 2
- Target Price
- AUDC $11.67
- DRTS $8.00
- AVG Volume (30 Days)
- AUDC 100.4K
- DRTS 41.7K
- Earning Date
- AUDC 07-29-2025
- DRTS 08-13-2025
- Dividend Yield
- AUDC 3.55%
- DRTS N/A
- EPS Growth
- AUDC 57.57
- DRTS N/A
- EPS
- AUDC 0.56
- DRTS N/A
- Revenue
- AUDC $242,474,000.00
- DRTS N/A
- Revenue This Year
- AUDC $1.54
- DRTS N/A
- Revenue Next Year
- AUDC $1.41
- DRTS N/A
- P/E Ratio
- AUDC $19.27
- DRTS N/A
- Revenue Growth
- AUDC N/A
- DRTS N/A
- 52 Week Low
- AUDC $7.70
- DRTS $1.93
- 52 Week High
- AUDC $12.72
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- AUDC 70.18
- DRTS 49.38
- Support Level
- AUDC $8.89
- DRTS $3.01
- Resistance Level
- AUDC $9.85
- DRTS $3.30
- Average True Range (ATR)
- AUDC 0.35
- DRTS 0.15
- MACD
- AUDC 0.09
- DRTS -0.02
- Stochastic Oscillator
- AUDC 76.88
- DRTS 19.71
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.